While everyone is busy buying weekly calls thinking Novo Nordisk ($NVO) is a bulletproof money printer because of Ozempic, their next massive blockbuster pipeline just completely bricked. Novo scraps two more heart drug trials, further dimming growth beyond obesity
CryptoAlerta — análise de criptomoedas e mercado em tempo real